Skip to main content
Chemiesynth (Vapi) Limited logo

Chemiesynth (Vapi) Limited — Investor Relations & Filings

Ticker · 539230 ISIN · INE829R01018 LEI · 98450052KC67GD0B3A31 BSE.NS Manufacturing
Open in API
Filings indexed 3 across all filing types
Latest filing 2026-05-27 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS 539230

About Chemiesynth (Vapi) Limited

https://www.chemiesynth.com

Chemiesynth (Vapi) Limited specializes in the manufacturing of specialty chemicals and intermediates for diverse industrial applications. The company focuses on the production of high-quality chemical intermediates used in the synthesis of dyes, pigments, pharmaceuticals, and agrochemicals. Its core technical competencies include complex chemical processes such as chlorination, nitration, and hydrogenation. Chemiesynth operates advanced manufacturing facilities equipped with modern R&D laboratories to support custom synthesis and process optimization. The organization serves a global clientele, providing performance chemicals that meet international quality standards. With a commitment to technical excellence and sustainable manufacturing practices, the company maintains a significant presence in the global chemical supply chain, catering to the specific requirements of the life sciences and material sciences sectors.

Recent filings

Filing Released Lang Actions
Audited Financial Results along with Auditor''s Report for the Quarter & Year ended 31.03.2026
Interim / Quarterly Report Classification · 88% confidence The document is a SEBI‐mandated disclosure filed with BSE under Regulation 30 and Regulation 33, containing the Board meeting outcome and the full audited financial results for the quarter and year ended March 31, 2026, together with the Statutory Auditor’s report, P&L and balance sheet. It is not merely an announcement of publication, nor a US-style earnings teaser, but a detailed interim/quarterly financial report. Accordingly, this matches the “Interim / Quarterly Report” category (IR). FY 2026
2026-05-27 English
outcome of the meeting of the Board of director held on held on 27th May 2026
Audit Report / Information Classification · 90% confidence The document is a statutory disclosure under SEBI LODR, comprising (1) the board’s approval of audited quarterly and annual financial results and (2) the Independent Auditor’s Report on those results, complete with auditor’s opinion, basis of opinion, management’s responsibilities, and the detailed statement of standalone audited financial results. It is not a full annual report (10-K), nor merely an earnings highlight (ER), nor a proxy/material solicitation. The centerpiece is the standalone audit report on the financial results, fitting the definition of Audit Report / Information (AR). FY 2026
2026-05-27 English
Chemiesynth (Vapi) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 ,inter alia, to consider and approve Audited Financial Results ....
Regulatory Filings Classification · 80% confidence The document is an intimation to the stock exchange under SEBI LODR Regulation 29 about a forthcoming board meeting to consider and approve audited financial results. It is a regulatory compliance announcement rather than the report itself or a change in management, earnings release, or dividend notice. It does not contain substantive financial data but informs the regulator and public of the board meeting date. This falls under general regulatory filings.
2026-05-20 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.